Gut-brain signaling, epigenetic genome reset, and AI drug discovery converging on aging reversal
| |

From the Gut to the Genome: Three Converging Breakthroughs Redefine Aging Reversal in 2026

A landmark Nature study, the first FDA-cleared epigenetic reprogramming trial, and a next-generation AI drug discovery model converged in early 2026, signaling that aging reversal science has crossed into clinical…

Scientists in a modern research laboratory representing longevity breakthroughs 2026 in AI drug discovery, epigenetic reprogramming, and gut-brain research
| |

AI Drugs, Epigenetic Reset, and the Gut-Brain Memory Fix: Longevity Science’s Defining Breakthroughs of 2026

In the span of just a few months, 2026 has delivered three of the most significant findings in longevity research history: the first AI-designed drug to show clinical efficacy in…